NAMUSCLA est indiqué dans le traitement symptomatique des myotonies dystrophiques chez l’adulte;
eNq1mF1v2jAUhu/5FVHuSQLlq1Og2li7Ia0ao0WbdoNMcihmwU6PbaD79XMI3ejkqK2pL2M77znxef34KPHFbp15G0BBOev7jSDyPWAJTym76/vT26t6z78Y1OIV2ZCjZd0gChpN30syIkTfL2aDORAmgh/XXz6Cfh/QH9S8mM9XkMgn65SkWfCZiOU1yYs1XrzhNPXWIJc87fu5kvtRLxYSdRaDLcdfIicJxOFh5Hh2NWsdj8dhIfYCVSUAvxB2ZxQFZqWZKERgckgk3HF8MEovklmz1+1EUc8qBBUTEFxhAmMil2PkG5pCao5EMgFWQRbb9AZwk4EsghjFw1WyFlbiZEV2E7gfmZN+r2eHcifrUb3Rbbfa7ei8043aZ1ah8GirzObRHxHms7Nmq9PodkJgISNrJbRb62vYUb0BlIFlncYcJckcVYiK4VOvOYqDcP+sE1Iq8ow8BCuR224VQaKnATUR3H1I8QW3qBmV6T37T5+pLAtfmfX0QBBHGReAGnLFZAVIria2GzHkTMKuuqJ27JO7gxcpiLeT/c2ZmftjNc9oYos3DSAFQk4no2q6uQLDByJgiu7I8J2ylG/F2xPnuMKOss/30DSK5pg2Zs3zXqfRblsfqJ/aThU3z6VCnkOoWUTFKYgZsQU/FS7aoWapR386sea+JeIJyaCiKapbMkd78rGHc+Z6dyeqnDCKfrq8tbXKNwX4cLN/NErTtP+3yHZAdkF5bczKxF9v8/K0v6BdbvXOmnaWRjNMllLm4l0YbrfbYElEXRC9WcECnYL/6N5117g7udzLZqeEp6PU5+Wt+Lpq2R6+567/U1vaw/uH1tkYQ6KCE2pRctoZTUeXbw/of/2ss7THT4DiLsy+9ySScuaqD1JzcxN00pWg68quUAPi62JBK/6nVPoyDst/OYNaHBb/cQa1P77d+1g=
TXUnVLW0rCmmAWLe